23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Tandem Diabetes Care, Inc. › 2025-2026

Tandem Diabetes Care, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Tandem Diabetes Care, Inc.’s Form 8-K, filed May 21, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 14Ballot items
  • 309Asset managers, any item
  • 4,049Fund votes
  • May 20, 2026Meeting date

Results at a glance

Meeting of May 20, 2026: 14 items on Tandem Diabetes Care, Inc.’s Form 8-K, filed May 21, 2026: 5 approved · 9 passed (calculated).

Dissent

Notable dissent: 1 director (12.8% against); 1 other board item (16.5% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Tandem Diabetes Care, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Tandem Diabetes Care, Inc.

These tallies are Tandem Diabetes Care, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 21, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Tandem Diabetes Care, Inc. — official shareholder meeting results, meeting held May 20, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Rebecca Robertson 54,160,282799,31025,702 --2,979,081 99%Passed (calculated)—
Elect Director: Sandra Beaver 54,607,191348,05030,053 --2,979,081 99.4%Passed (calculated)—
Elect Director: Myoungil Cha 54,456,358502,29026,646 --2,979,081 99.1%Passed (calculated)—
Elect Director: Peyton Howell 54,179,597773,22032,477 --2,979,081 99%Passed (calculated)—
Elect Director: Joao Malagueira 54,454,159499,74731,388 --2,979,081 99.1%Passed (calculated)—
Elect Director: Kathleen McGroddy-Goetz 54,312,399641,72631,169 --2,979,081 99%Passed (calculated)—
Elect Director: John Sheridan 54,432,569536,16416,561 --2,979,081 99.0%Passed (calculated)—
Elect Director: Rajwant Sodhi 54,328,131621,29535,868 --2,979,081 99%Passed (calculated)—
Elect Director: Christopher Twomey 47,921,6557,034,20829,431 --2,979,081 87%Passed (calculated)—
2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement 53,460,7471,481,02743,520 --2,979,081 97%Approved—
3. To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan 53,846,6961,108,52930,069 --2,979,081 98%Approved—
4. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the DGCL 57,818,029126,02520,321 --0 99.8%Approved—
5. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DG 45,926,4059,043,83115,058 --2,979,081 84%Approved—
6. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 57,493,084454,73516,556 --0 99.2%Approved—

Source: Tandem Diabetes Care, Inc., Form 8-K, filed with the SEC on May 21, 2026 — read the filing on EDGAR.

How asset managers voted at the Tandem Diabetes Care, Inc. 2025-2026 meeting

309 asset managers disclosed a vote on at least one Tandem Diabetes Care, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Rebecca Robertson

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 54,160,282AGAINST: 799,310

Prior year: 99.4% for (May 21, 2025 meeting) ▼ 0.9 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Robertson

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Rebecca Robertson”): 54,160,282 for, 799,310 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,055,357 for, 69,427 against.

FOR
FOR: 25,055,357AGAINST: 69,427
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rebecca Rober” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,771,76629,157 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Sandra Beaver

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.4% Majority: yes · of votes cast

FOR 99.4%
FOR: 54,607,191AGAINST: 348,050
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Sandra Beaver”): 54,607,191 for, 348,050 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,095,683 for, 29,100 against.

FOR
FOR: 25,095,683AGAINST: 29,100
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Sandra Beaver” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,790,26310,659 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street769,4490 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Myoungil Cha

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 54,456,358AGAINST: 502,290

Prior year: 99.7% for (May 21, 2025 meeting) ▼ 0.6 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Myoungil Cha”): 54,456,358 for, 502,290 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,090,044 for, 34,740 against.

FOR
FOR: 25,090,044AGAINST: 34,740
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Myoungil Cha” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42618,497 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Peyton Howell

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 54,179,597AGAINST: 773,220

Prior year: 98.9% for (May 21, 2025 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Peyton Howell”): 54,179,597 for, 773,220 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,090,039 for, 34,745 against.

FOR
FOR: 25,090,039AGAINST: 34,745
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Peyton Howell” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42118,502 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Joao Malagueira

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.1% Majority: yes · of votes cast

FOR 99.1%
FOR: 54,454,159AGAINST: 499,747

Prior year: 99.6% for (May 21, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malagueira

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Joao Malagueira”): 54,454,159 for, 499,747 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,090,044 for, 34,740 against.

FOR
FOR: 25,090,044AGAINST: 34,740
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Joao Malaguei” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42618,497 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Kathleen McGroddy-Goetz

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 54,312,399AGAINST: 641,726

Prior year: 99.0% for (May 21, 2025 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGroddy-Goetz

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Kathleen McGroddy-Goetz”): 54,312,399 for, 641,726 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,084,456 for, 40,328 against.

FOR
FOR: 25,084,456AGAINST: 40,328
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Kathleen McGr” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42418,499 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: John Sheridan

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 54,432,569AGAINST: 536,164

Prior year: 99.6% for (May 21, 2025 meeting) ▼ 0.5 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: John Sheridan”): 54,432,569 for, 536,164 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,090,043 for, 34,740 against.

FOR
FOR: 25,090,043AGAINST: 34,740
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: John Sheridan” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42518,497 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Rajwant Sodhi

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 54,328,131AGAINST: 621,295

Prior year: 99.0% for (May 21, 2025 meeting) ▼ 0.1 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Rajwant Sodhi”): 54,328,131 for, 621,295 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,084,456 for, 40,328 against.

FOR
FOR: 25,084,456AGAINST: 40,328
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Rajwant Sodhi” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42418,499 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,606843 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Elect Director: Christopher Twomey

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 4 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%
FOR: 47,921,655AGAINST: 7,034,208

Prior year: 84.8% for (May 21, 2025 meeting) ▲ 2.4 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher Twomey

Tandem Diabetes Care, Inc.’s own tally for this item (“Elect Director: Christopher Twomey”): 47,921,655 for, 7,034,208 against, per its Form 8-K filed May 21, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 22,348,478 for, 2,776,306 against.

FOR
FOR: 22,348,478AGAINST: 2,776,306
Largest asset managers voting on “To elect nine directors for a one-year term expiring at the 2027 annual meeting of stockholders: Christopher T” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,231,7501,569,173 00Mixed
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC0907,331 00Against
State Street768,2831,166 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes099,752 00Against
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II060,070 00Against
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%
FOR: 57,818,029AGAINST: 126,025
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the Delaware General Corporation Law ("DGCL").

Tandem Diabetes Care, Inc.’s own tally for this item (“4. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for removal of directors with or without cause, as required by Section 141(k) of the DGCL”): 57,818,029 for, 126,025 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “This proposal was approved and the voting results were as follows:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,124,784 for.

FOR
FOR: 25,124,784
Largest asset managers voting on “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to provide for remo” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,800,9230 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street769,4490 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i)…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

84% Approved · of votes cast

FOR 84%AGAINST
FOR: 45,926,405AGAINST: 9,043,831
Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted pursuant to Section 102(b)(7) of the DGCL, and (ii) implement certain other changes based on updates to the DGCL.

Tandem Diabetes Care, Inc.’s own tally for this item (“5. To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other things, (i) limit the liability of officers of the Company to the maximum extent permitted by law as permitted”): 45,926,405 for, 9,043,831 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “This proposal was approved and the voting results were as follows:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 21,478,971 for, 3,645,814 against.

FORAGAINST
FOR: 21,478,971AGAINST: 3,645,814
Largest asset managers voting on “To approve an amendment to the Company's Amended and Restated Certificate of Incorporation to, among other thi” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard7,250,2331,550,690 00Mixed
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC0907,331 00Against
State Street769,126323 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS0552,296 00Against
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan0237,062 00Against
Mercer Funds0178,258 00Against
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs72,59525,029 00Mixed
NORTHERN LIGHTS FUND TRUST II060,070 00Against
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan

Official resultFund totals may overlapOTHER SOCIAL ISSUESReported outcome: Approved

98% Approved · of votes cast

FOR 98%
FOR: 53,846,696AGAINST: 1,108,529
Details: description as filed, official tally, votes by 72 asset managers

Description as filed by funds: To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares authorized for issuance under the plan.

Tandem Diabetes Care, Inc.’s own tally for this item (“3. To approve the Amended Plan to, among other things, increase the number of shares authorized for issuance under the plan”): 53,846,696 for, 1,108,529 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “This proposal was approved and the voting results were as follows:”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of Tandem Diabetes Care, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Amend Omnibus Stock Plan” (3 managers, 78,599 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 69 asset managers voting on “To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the numbe” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,782,42118,502 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street768,558891 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Fund voting reports, all 69 managers: 24,977,202 for, 68,983 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 3 asset managers voting on “To approve the Company's 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the numbe” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
First Light Asset Management, LLC1,190,5400 00For
Vident Advisory, LLC4,0720 00For
Boltwood Capital Management1250 00For

Institutional-manager reports, all 3 managers: 1,194,737 for.

To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described…

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

97% Approved · of votes cast

FOR 97%
FOR: 53,460,747AGAINST: 1,481,027

Prior year: 97.1% for (May 21, 2025 meeting) ▲ 0.2 pts

Details: description as filed, official tally, votes by 309 asset managers

Description as filed by funds: To approve, on a non-binding, advisory basis, the compensation of our named executive officers.

Tandem Diabetes Care, Inc.’s own tally for this item (“2. To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as described in the Proxy Statement”): 53,460,747 for, 1,481,027 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “This proposal was approved and the voting results were as follows:”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 72 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,800,9194 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street769,4490 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen0258,774 00Against
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Fund voting reports, all 72 managers: 24,866,006 for, 258,778 against. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 261 asset managers voting on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Sessa Capital IM, L.P.5,000,0000 00For
ArrowMark Colorado Holdings LLC2,827,2120 00For
BlackRock2,473,5750 00For
GW&K Investment Management, LLC25,0290 00For
State Street1,942,6012,083 00For
DRIEHAUS CAPITAL MANAGEMENT LLC1,690,3000 00For
GEODE CAPITAL MANAGEMENT, LLC1,615,3400 00For
First Light Asset Management, LLC1,190,5400 00For
JENNISON ASSOCIATES LLC965,1090 00For
JACOBS LEVY EQUITY MANAGEMENT, INC957,1350 00For
BAILLIE GIFFORD & CO LTD740,5900 00For
Wellington714,8730 00For
DE Shaw699,9090 00For
Fidelity641,2330 00For
Charles Schwab640,0120 00For
Northern Trust624,5510 00For
Vanguard578,2610 00For
Aberdeen0547,035 00Against
Voya510,9440 00For
MARSHALL WACE, LLP446,0540 00For
Freestone Grove Partners LP443,1050 00For
Point72432,2530 00For
Nuveen362,0290 00For
DAFNA Capital Management LLC355,2080 00For
Royce337,5540 00For

Institutional-manager reports, all 261 managers: 31,960,537 for, 1,209,295 against, 27 abstained, 2,392 not voted, 2,331,190 mixed. Showing the 25 largest; every one is in the interactive database (link above).

To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 3 wordings of this item as funds reported it.

99.2% Approved · of votes cast

FOR 99.2%
FOR: 57,493,084AGAINST: 454,735

Prior year: 98.9% for (May 21, 2025 meeting) ▲ 0.3 pts

Details: description as filed, official tally, votes by 73 asset managers

Description as filed by funds: To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

Tandem Diabetes Care, Inc.’s own tally for this item (“6. To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026”): 57,493,084 for, 454,735 against — passed, per its Form 8-K filed May 21, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “This proposal was approved and the voting results were as follows:”
Support: 99.2% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 73 asset managers below reported 25,096,131 for, 28,654 against.

FOR
FOR: 25,096,131AGAINST: 28,654
Largest asset managers voting on “To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fi” at Tandem Diabetes Care, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard8,800,9212 00For
BlackRock6,636,4490 00For
Fidelity2,145,4190 00For
MERIDIAN FUND INC907,3310 00For
State Street769,40148 00For
Prudential/PGIM630,2680 00For
Charles Schwab557,2040 00For
AMG FUNDS552,2960 00For
Royce358,9960 00For
Voya352,9110 00For
First Trust340,0040 00For
TIAA336,2620 00For
Aberdeen258,7740 00For
DRIEHAUS MUTUAL FUNDS254,5470 00For
JPMorgan237,0620 00For
Mercer Funds178,2580 00For
Equitable142,1500 00For
RBB FUND, INC.122,6780 00For
QUANTITATIVE MASTER SERIES LLC109,6740 00For
Jackson National106,2290 00For
Columbia Threadneedle104,5030 00For
Federated Hermes99,7520 00For
Goldman Sachs97,6240 00For
NORTHERN LIGHTS FUND TRUST II60,0700 00For
Principal59,3430 00For

Showing the 25 largest of 73 asset managers. All 73 are in the interactive database (link above).

Largest Tandem Diabetes Care, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 68,529,089 shares outstanding at the time of that meeting.

Fund voting reports: top Tandem Diabetes Care, Inc. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Vanguard 12.84%
2BlackRock 9.68%
3Fidelity 3.13%
4MERIDIAN FUND INC 1.32%
5State Street 1.12%
6Prudential/PGIM 0.92%
7Charles Schwab 0.81%
8AMG FUNDS 0.81%
9Royce 0.52%
10Voya 0.51%
Institutional-manager reports: top Tandem Diabetes Care, Inc. shareholders by shares voted on “To approve, on a non-binding, advisory basis, the compensation of our named executive officers.”, 2025-2026
#Asset manager % of shares outstanding
1Sessa Capital IM, L.P. 7.30%
2ArrowMark Colorado Holdings LLC 4.13%
3BlackRock 3.61%
4GW&K Investment Management, LLC 3.44%
5State Street 2.84%
6DRIEHAUS CAPITAL MANAGEMENT LLC 2.47%
7GEODE CAPITAL MANAGEMENT, LLC 2.36%
8First Light Asset Management, LLC 1.74%
9JENNISON ASSOCIATES LLC 1.41%
10JACOBS LEVY EQUITY MANAGEMENT, INC 1.40%

Reported Tandem Diabetes Care, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Tandem Diabetes Care, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
BlackRock10,690,844 15.60%Form 13F, quarter ended March 31, 2026
The Vanguard Group7,021,906 10.25%Proxy statement (DEF 14A), table as of March 16, 2026
Sessa Capital4,466,307 6.52%Proxy statement (DEF 14A), table as of March 16, 2026
Vanguard Portfolio Management4,052,274 5.91%Schedule 13G, filed April 29, 2026
ArrowMark Colorado Holdings, LLC2,889,691 4.22%Schedule 13G, filed February 17, 2026
State Street2,662,260 3.88%Form 13F, quarter ended March 31, 2026
Citadel Advisors2,277,167 3.32%Form 13F, quarter ended March 31, 2026
Goldman Sachs2,218,922 3.24%Form 13F, quarter ended March 31, 2026
Morgan Stanley2,080,497 3.04%Form 13F, quarter ended March 31, 2026
Two Sigma1,864,194 2.72%Form 13F, quarter ended March 31, 2026

Percentages above are of 68,529,089 shares outstanding, as reported by Tandem Diabetes Care, Inc. on its Form 10-Q dated May 4, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Tandem Diabetes Care, Inc.'s shareholder meeting held May 20, 2026, in the 2025-2026 proxy season, 309 asset managers reported votes on at least one of its 14 ballot items in their SEC Form N-PX filings, covering 4,049 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding, advisory basis, the compensation of our named executive officers. — Tandem Diabetes Care, Inc.'s filing reports the proposal as approved, with 97% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Tandem Diabetes Care, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 21, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Tandem Diabetes Care, Inc.’s 10-Q dated May 4, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Tandem Diabetes Care, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Tandem Diabetes Care (TNDM) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/tandem-diabetes-care-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.